MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MS patients switch meds – will it work as well?
Disease control OngoingThis study looks at 184 people with relapsing-remitting multiple sclerosis who switched from the drug MabThera to a similar drug called Rixathon. Researchers want to see if the switch changes nerve damage, brain lesions, relapses, or disability. They will use existing medical rec…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Sponsor: Uppsala University • Aim: Disease control
Last updated May 17, 2026 04:25 UTC
-
Cycle-Smart workouts: a new hope for MS fatigue?
Symptom relief OngoingThis study looks at whether matching exercise routines to the phases of the menstrual cycle can reduce fatigue and improve quality of life in women with relapsing-remitting Multiple Sclerosis (MS). About 20 women with MS and a similar group without MS will take part. The goal is …
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Universidad de Almeria • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Healthy habits program aims to ease MS fatigue and boost Well-Being
Symptom relief OngoingThis study tests whether educational programs about exercise, the Mediterranean diet, and mental strategies can improve quality of life and reduce fatigue in women with relapsing-remitting multiple sclerosis. About 60 participants will be assigned to either supervised or self-gui…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Universidad de Almeria • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC